Free Online CME

Disease Management Clinical Decisions

Psoriasis 

Print this Content

Release date: October 22, 2019
Expiration date: October 22, 2022

Estimated Time of Completion: 45 minutes

Description

Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

Learning Objectives

After completing this case the reader should be able to:

  • Discuss strategies for assessing psoriasis severity and its value in selecting appropriate treatment options.
  • Describe the relationship between psoriasis and psoriatic arthritis and the importance of screening for psoriatic arthritis in patients with psoriasis.
  • Recognize treat-to-target goals for patients with moderate-to-severe psoriasis.
  • Summarize the safety and efficacy of the various biologic classes available to treat psoriasis.
  • Debate the evidence linking biologic treatment with the risk of future cardiovascular events in patients with psoriasis.

Target Audience

Directed to primary care physicians including family practitioners and internists.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ABA MOC: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

Successful completion of this activity enables the participant to earn up to 0.75 MOCA 2.0 points, points earned will be equivalent to the amount of CME credit claimed for the activity.  Please Note: It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting MOCA 2.0™ points.

Maintenance of Certification in Anesthesiology™ program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of The American Board of Anesthesiology®.

Your credit will be reported to the ABA within 60 days of claiming credit after the course.

ABIM MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Your credit will be reported to the ABIM within 60 days of claiming credit after the course. 

ABO MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning, Self-Assessment, Improvement in Medical Practice and/or Patient Safety requirements for the American Board of Ophthalmology’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit. 

Your credit will be reported to the ABO within 60 days of claiming credit after the course. 

ABOHNS MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to meet the expectations of the American Board of Otolaryngology’s Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

Your credit will be reported to the ABOHNS within 60 days of claiming credit after the course. 

ABPath MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Lifelong Learning (Part II) / Self-Assessment Module (SAM) credits in the American Board of Pathology’s Maintenance of Certification Program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit. 

Your credit will be reported to the ABPath within 60 days of claiming credit after the course. 

ABP MOC:  Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. 

Your credit will be reported to the ABP within 60 days of claiming credit after the course.

ABS MOC: This activity qualifies for 0.75 self-assessment credits toward Part 2 of the American Board of Surgery (ABS) Maintenance of Certification (MOC) Program.

Please Note:  It is the participant’s responsibility to self-report their participation to the American Board of Surgery, per board policy. 

Activity Director and Faculty

Activity Director

Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Co-Medical Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Anthony Fernandez, MD, PhD
  Novartis Consulting; Independent contractor (including contracted research); Teaching and Speaking
  Abbvie Pharmaceuticals Consulting; Teaching and Speaking
  Celgene Corporation Consulting
  Mallinckrodt Inc. Independent contractor (including contracted research);
Teaching and Speaking
  Pfizer, Inc. Independent contractor (including contracted research)
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial

 

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education.